Similar articles

• Dapoxetine in the treatment of premature ejaculation.

  McMahon C. McMahon C. Clin Neuropharmacol. 2007 Sep-Oct;30(5):314-5. doi: 10.1097/wnf.0b013e31815766f9. Clin Neuropharmacol. 2007. PMID: 17909313 No abstract available.
• Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation.

  Simsek A, Kirecci SL, Kucuktopcu O, Ozgor F, Akbulut MF, Sarilar O, Ozkuvanci U, Gurbuz ZG. Simsek A, et al. Asian J Androl. 2014 Sep-Oct;16(5):725-7. doi: 10.4103/1008-682X.128467. Asian J Androl. 2014. PMID: 24830690 Free PMC article. Clinical Trial.
• Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.

  Safarinejad MR. Safarinejad MR. Clin Neuropharmacol. 2006 Sep-Oct;29(5):243-52. doi: 10.1097/01.WNF.0000228210.12194.46. Clin Neuropharmacol. 2006. PMID: 16960468 Clinical Trial.
• Dapoxetine for premature ejaculation.

  McMahon CG. McMahon CG. Expert Opin Pharmacother. 2010 Jul;11(10):1741-52. doi: 10.1517/14656566.2010.493174. Expert Opin Pharmacother. 2010. PMID: 20540653 Review.
• A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.

  Hutchinson K, Cruickshank K, Wylie K. Hutchinson K, et al. Drug Saf. 2012 May 1;35(5):359-72. doi: 10.2165/11598150-000000000-00000. Drug Saf. 2012. PMID: 22452563 Review.